✦ LIBER ✦

Predicting the status of axillary sentinel lymph nodes in 4351 patients with invasive breast carcinoma treated in a single institution

✍ Scribed by Giuseppe Viale; Stefano Zurrida; Eugenio Maiorano; Giovanni Mazzarol; Giancarlo Pruneri; Giovanni Paganelli; Patrick Maisonneuve; Umberto Veronesi

Publisher: John Wiley and Sons
Year: 2005
Tongue: English
Weight: 94 KB
Volume: 103
Category: Article
ISSN: 0008-543X
DOI: 10.1002/cncr.20809

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

BACKGROUND

Reliable predictors of metastatic involvement would enable a better selection of candidate patients for sentinel lymph node biopsy (SLNB) and possibly allow identification of patients with such a low risk of axillary sentinel lymph node (SLN) involvement to be even spared SLNB.

METHODS

The authors evaluated 4351 consecutive patients surgically treated for breast carcinoma who also underwent SLNB. Clinicopathologic features significantly associated with SLN metastases by univariate analysis were included in a multivariate model.

RESULTS

By multivariate analysis, the prevalence of SLN metastases was associated directly with tumor size, multifocality, and with the occurrence of peritumoral vascular invasion (PVI; all P < 0.0001), and was associated inversely with a favorable histotype (P = 0.0007) and lack of progesterone receptors (P = 0.004). A predictive model based on the features more closely associated with SLN status documented that the patients with a favorable tumor type ≤ 1 cm in size and without PVI (n = 178 [4% of the population]) had the lowest risk of SLN metastases (9.5%) whereas patients with tumors > 2 cm and with PVI (n = 250 [5.7% of the population]) had the highest risk (77.2%) of SLN involvement.

CONCLUSIONS

Tumor size and PVI emerged as the most powerful independent predictors of SLN metastases. Although no combination of features identified patients with a < 9.5% risk of SLN metastases, the current data may be used to tailor the management of patients with breast carcinoma with the aim of minimizing as much as possible the diagnostic and therapeutic procedures, thus improving the quality of life of the patients without any adverse effect on their survival rates. Cancer 2005 © 2004 American Cancer Society

📜 SIMILAR VOLUMES

Optimal use of sentinel lymph node biops

Optimal use of sentinel lymph node biopsy versus axillary lymph node dissection in patients with breast carcinoma : A decision analysis

✍ Sandra L. Wong; Troy D. Abell; Celia Chao; Michael J. Edwards; Kelly M. McMaster 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 112 KB 👁 1 views

## Background: There are no data available from randomized controlled trials that compare the efficacy of sentinel lymph node (sln) biopsy with level i/ii axillary lymph node dissection (alnd) in patients with breast carcinoma. we performed a formal decision analysis to determine whether sln biopsy

Initial experience in a community hospit

Initial experience in a community hospital with sentinel lymph node mapping and biopsy for evaluation of axillary lymph node status in palpable invasive breast cancer

✍ Morgan, Alan; Howisey, Robert L.; Aldape, Hector C.; Patton, Richard G.; Rowboth 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 130 KB 👁 2 views

Background and Objectives: To determine the sentinel node detection rate and the accuracy with which the sentinel node histology reflects that of the axilla in a series of patients with palpable invasive breast cancer. Methods: Forty-four patients with clinically node-negative palpable invasive T1 o

Validation of axillary sentinel lymph no

Validation of axillary sentinel lymph node detection in the staging of early lobular invasive breast carcinoma : A prospective study

✍ Jean-Marc Classe; Delphine Loussouarn; Loïc Campion; Maryse Fiche; Chantal Curte 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 90 KB 👁 1 views

## Abstract ## BACKGROUND Previous reports have shown that regional lymph node involvement in patients with early‐stage breast carcinoma can be evaluated by resection of axillary sentinel lymph nodes (ASLN). Axillary lymphadenectomy may be unnecessary in the absence of ASLN involvement. In the cur

Prediction of tumour involvement in rema

Prediction of tumour involvement in remaining axillary lymph nodes when the sentinel node in a woman with breast cancer contains metastases

✍ C. Nos; C. Harding-MacKean; P. Fréneaux; A. Trie; M. C. Falcou; X. Sastre-Garau; 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 108 KB 👁 2 views

Clinicopathologic characteristics of 143

Clinicopathologic characteristics of 143 patients with synchronous bilateral invasive breast carcinomas treated in a single institution

✍ Mattia Intra; Nicole Rotmensz; Giuseppe Viale; Luigi Mariani; Bernardo Bonanni; 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 91 KB

## Abstract ## BACKGROUND Synchronous bilateral invasive breast carcinoma (SBIBC) ranged in incidence from 0.3% to as high as 12%. ## METHODS Between April 1997 and February 2003, 143 consecutive patients with SBIBC were treated at the European Institute of Oncology (Milan, Italy). Their informa

Occult metastases in the sentinel lymph

Occult metastases in the sentinel lymph nodes of patients with early stage breast carcinoma : A preliminary study

✍ Kambiz Dowlatshahi; Ming Fan; Kenneth J. Bloom; Daniel J. Spitz; Samir Patel; Ho 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 398 KB 👁 2 views

## BACKGROUND. Thirty percent of lymph node negative patients with operable breast carcinoma experience disease recurrence within 10 years. Retrospective serial sectioning of axillary lymph nodes has revealed undetected metastases in 9 -30% of these patients. These occult metastases have been show